Home › Non-Small Cell Lung Cancer › New York › Buffalo
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Buffalo, NY
19 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Buffalo (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Nagre-recruitPhase 3
- Roswell Park Cancer Institute, Buffalo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Roswell Park Cancer Institute, Buffalo
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Nagre-recruitPhase 3
- Roswell Park Cancer Institute ( Site 0184), Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- Roswell Park Cancer Institute IDS, Buffalo
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Nagre-recruitPhase 3
- Roswell Park Cancer Institute, Buffalo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Research Site, Buffalo
Intratumoral N17350 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Nagre-recruitPhase 2
- Research Site, Buffalo
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Research Site, Buffalo
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Nagre-recruitPhase 1
- Roswell Park Cancer Institute, Buffalo
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
Nagre-recruitPhase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
Nagre-recruitPhase 2
- Roswell Park Cancer Institute, Buffalo
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Roswell Park Comprehensive Care Center, Buffalo
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Nagre-recruitPhase 1
- Roswell Park Cancer Institute, Buffalo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Nagre-recruitPhase 1
- Roswell Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Buffalo
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
Nagre-recruit
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Nagre-recruitPhase 1/2
- Roswell Park Cancer Institute, Buffalo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Buffalo
- Kanser (lahat ng uri)19 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Kanser sa Baga16 pag-aaral
- Kanser sa Suso16 pag-aaral
- Kanser sa Ovary13 pag-aaral
- Metastatic Cancer11 pag-aaral
- Kanser sa Prostate11 pag-aaral
- Melanoma10 pag-aaral
- Multiple Myeloma10 pag-aaral
- Obesity9 pag-aaral
- Burkitt Lymphoma8 pag-aaral
- Myelodysplastic Syndromes8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.